Cargando…
The LKB1 Tumor Suppressor as a Biomarker in Mouse and Human Tissues
Germline mutations in the LKB1 gene (also known as STK11) cause the Peutz-Jeghers Syndrome, and somatic loss of LKB1 has emerged as causal event in a wide range of human malignancies, including melanoma, lung cancer, and cervical cancer. The LKB1 protein is a serine-threonine kinase that phosphoryla...
Autores principales: | Nakada, Yuji, Stewart, Thomas G., Peña, Christopher G., Zhang, Song, Zhao, Ni, Bardeesy, Nabeel, Sharpless, Norman E., Wong, Kwok-Kin, Hayes, D. Neil, Castrillon, Diego H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783464/ https://www.ncbi.nlm.nih.gov/pubmed/24086281 http://dx.doi.org/10.1371/journal.pone.0073449 |
Ejemplares similares
-
Somatic LKB1 Mutations Promote Cervical Cancer Progression
por: Wingo, Shana N., et al.
Publicado: (2009) -
LKB1 tumor suppressor: Therapeutic opportunities knock when LKB1 is inactivated
por: Zhou, Wei, et al.
Publicado: (2014) -
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
por: Zhang, Haikuo, et al.
Publicado: (2017) -
Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
por: Zhang, Haikuo, et al.
Publicado: (2017) -
The Tumor Suppressor Kinase LKB1: Metabolic Nexus
por: Bourouh, Mohammed, et al.
Publicado: (2022)